Amarin Corp PLC (NAS:AMRN)
$ 0.8475 0.0032 (0.38%) Market Cap: 348.21 Mil Enterprise Value: 48.42 Mil PE Ratio: 0 PB Ratio: 0.64 GF Score: 42/100

Amarin Corporation PLC at Goldman Sachs Healthcare Conference Transcript

Jun 12, 2023 / 09:40PM GMT
Release Date Price: $1.27 (+0.79%)
Paul Choi
Goldman Sachs Group, Inc., Research Division - Equity Analyst

Okay. We'll continue with our next session. I'm Paul Choi, and I cover the small and mid-cap biotechnology sector here at Goldman Sachs. Our next session is with Amarin and we're joined by 2 members of the management team. To my immediate left is the CEO, Aaron Berg, and to my follow-up, CFO, Tom Reilly. What we'll do is Q&A as we have in prior sessions. If there are questions along the way from the audience, please feel free to raise your hand and we can get a mic to you. Alternatively, if you want to ask a question anonymously, please feel free to send me an e-mail and I'll read the question out loud over the Internet for anybody who may have questions online.

Questions & Answers

Paul Choi
Goldman Sachs Group, Inc., Research Division - Equity Analyst

So maybe with that, I'll start with you, Aaron and then maybe you've been in the seat for a few weeks now and maybe high-level impressions as you've been in the job here and just kind of like how you're thinking about your

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot